About this trial
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.
Eligibility criteria
Qualifiers
Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease
Age 18 or older
Speak, read, and write English
Live in the United States
Disqualifiers
Possible dementia
Narcolepsy
Posttraumatic stress disorder
Previous behavioral treatment for nightmares
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy for Nightmares